Aberrant DNA methylation of GATA binding protein 3 (GATA3), interleukin-4 (IL-4), and transforming growth factor-&#x03B2; (TGF-&#x03B2;) promoters in Behcet’s disease

Yunyun Zhu; Yiguo Qiu; Hongsong Yu; Shenglan Yi; Wencheng Su; Aize Kijlstra; Peizeng Yang

doi:10.18632/oncotarget.19500

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Aberrant DNA methylation of GATA binding protein 3 (GATA3), interleukin-4 (IL-4), and transforming growth factor-β (TGF-β) promoters in Behcet’s disease

Yunyun Zhu, Yiguo Qiu, Hongsong Yu, Shenglan Yi, Wencheng Su, Aize Kijlstra and Peizeng Yang _

PDF | HTML | How to cite

Oncotarget. 2017; 8:64263-64272. https://doi.org/10.18632/oncotarget.19500

Metrics: PDF 1564 views | HTML 2670 views | ?

Abstract

Yunyun Zhu1, Yiguo Qiu1, Hongsong Yu1, Shenglan Yi1, Wencheng Su1, Aize Kijlstra2 and Peizeng Yang1

1The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Ophthalmology and Chongqing Eye Institute, Chongqing, China

2University Eye Clinic Maastricht, Maastricht, The Netherlands

Correspondence to:

Peizeng Yang, email: [email protected]

Keywords: DNA methylation, Behcet’s disease, CD4⁺ T cell

Received: May 19, 2017 Accepted: June 12, 2017 Published: July 22, 2017

ABSTRACT

The pathogenesis of Behcet’s disease (BD) remains poorly understood. The purpose of this study was to investigate whether an aberrant DNA methylation of transcriptional and inflammatory factors, including TBX21, GATA3, RORγt, FOXP3, IFN-γ, IL-4, IL-17A and TGF-β, in CD4⁺T confers risk to BD. We found that the promoter methylation level of GATA3, IL-4 and TGF-β was significantly up-regulated in active BD patients and negatively correlated with the corresponding mRNA expression. The mRNA expression of GATA3 and TGF-β was markedly down-regulated in active BD patients compared to healthy individuals. Treatment with corticosteroids and cyclosporine (CsA) resulted in a decrease of the methylation level of GATA3 and TGF-β in inactive BD patients. Our results suggest that an aberrant DNA methylation of GATA3 and TGF-β is associated with their mRNA expression and participates in the pathogenesis of BD.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 19500

Publication Alerts

Research Papers:

Aberrant DNA methylation of GATA binding protein 3 (GATA3), interleukin-4 (IL-4), and transforming growth factor-β (TGF-β) promoters in Behcet’s disease

Abstract